Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression
Joshua M. Poulin(Sunnybrook Health Science Centre), Sean M. Nestor(Sunnybrook Health Science Centre), Gregory E. Bigford(University of Miami), Jennifer S. Rabin(Sunnybrook Health Science Centre), Joshua D. Rosenblat(University Health Network), Krista L. Lanctôt(Sunnybrook Health Science Centre), Xingshan Cao(Sunnybrook Health Science Centre), Amit Singnurkar(McMaster University), Nir Lipsman(Sunnybrook Health Science Centre), Muhammad Ishrat Husain(University of Toronto), Christopher B. Pople(Sunnybrook Health Science Centre), Mark Sinyor(Sunnybrook Health Science Centre), Mario Masellis(Sunnybrook Health Science Centre), Peter Giacobbe(University of Toronto), Ayal Schaffer(University of Toronto), Bradley J. MacIntosh(Oslo University Hospital)
Cited by 4
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia
|Magnetic Resonance in Medicine|2014|2.2k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Suicide risk and prevention during the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.6k